Mirum Pharmaceuticals, Inc. (MIRM)

SEC filing

Mirum Pharmaceuticals, Inc.

MIRM · CIK 1759425

4 · Oct 6, 2026 · Director, CHIEF EXECUTIVE OFFICER Peetz Christopher exercised options for 24.39K shares

Director, CHIEF EXECUTIVE OFFICER Peetz Christopher exercised options for 24.39K shares

xslF345X06/form4-10072026_121019.xml

xslF345X06/form4-10072026_121019.xmlSEC.gov

Graphics and non-inline formats (not embedded below).